GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

AstraZeneca (AZ) has announced positive high-level results from a late-stage study of its AKT inhibitor Truqap (capivasertib) ...

Sanofi has announced the opening of its new €558m-backed manufacturing facility in Singapore, which the company says ...

Gastric cancer is the fifth leading cause of cancer-related deaths globally and oesophageal cancer is the sixth ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

Policymakers, payers, providers, patients and pharma are each uniquely able to impact health equity – and together, achieve ...

GSK’s linerixibat has shown promising results in a late-stage trial of primary biliary cholangitis (PBC) patients with ...

Novartis’ Kisqali (ribociclib) has been approved by the European Commission (EC) to reduce the risk of disease recurrence in ...

COP29 President-Designate around November’s global climate conference. And reviewing the insights from a recent look at how ...

The challenges facing the UK’s healthcare system and why putting the patient voice at the heart of our work is key ...

Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 ...

AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by ...